Back to Results

ITonic Holdings Ltd (ITOC)

iTonic Holdings Ltd. is a healthcare technology company listed on the NASDAQ under the symbol ITOC. The company develops and commercializes software and devices used in brachytherapy, a form of radiotherapy in which radioactive sources are placed inside the body to treat cancer. Its proprietary treatment planning system, FTTPS, is designed to support planning for malignant tumors by helping determine target volumes, prescription doses, and organ-at-risk dose limits, while also generating dose distribution plans for brachytherapy procedures. The company was founded in 1998 and is headquartered in Beijing, China. It was previously known as Pheton Holdings Ltd. and adopted its current name in January 2026. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-ITOC
$0.24
-23.6% Downside
Overvalued
Not available
Not available
Weak
0.0%
6.1x
71.6x
37.409 M
36.676 M
0.4%
91.7%
5.9
63.5%
Valuation • Fair Value

iTonic Holdings Ltd (NASDAQ-ITOC) Fair Value by Valuation Model

Review the available estimates for iTonic Holdings Ltd (NASDAQ-ITOC), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.24

Estimated downside of 23.6% versus the current market price.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.21

Discounted cash flow valuation reference.

Comps Fair Value

$0.26

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for iTonic Holdings Ltd (NASDAQ-ITOC) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for iTonic Holdings Ltd (NASDAQ-ITOC)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

523.031 K

Current operating scale indicator.

Revenue Forecast

588.41 K

Forward revenue estimate.

EBITDA

-5.174 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review iTonic Holdings Ltd (NASDAQ-ITOC) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for iTonic Holdings Ltd (NASDAQ-ITOC)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

1

Weak quality score that deserves closer review.

Beneish M-Score

-1,000.00

No elevated caution signal from this screen.

Altman Z-Score

5.9

Relatively strong balance-sheet zone.

FCF / Net Income

63.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for iTonic Holdings Ltd (NASDAQ-ITOC). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for iTonic Holdings Ltd (NASDAQ-ITOC)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for iTonic Holdings Ltd (NASDAQ-ITOC). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for iTonic Holdings Ltd (NASDAQ-ITOC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for iTonic Holdings Ltd (NASDAQ-ITOC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for iTonic Holdings Ltd (NASDAQ-ITOC) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for iTonic Holdings Ltd (NASDAQ-ITOC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for iTonic Holdings Ltd (NASDAQ-ITOC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

iTonic Holdings Ltd (NASDAQ-ITOC) Stock FAQ

Data-supported answers about iTonic Holdings Ltd (NASDAQ-ITOC), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.24
Estimated downside 23.6%
Valuation Rating
Overvalued
Estimated downside of 23.6%
Financial Health
Weak
Current financial-health read

The current fair value estimate for iTonic Holdings Ltd (NASDAQ-ITOC) is $0.24. This implies an estimated downside of 23.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 23.6% versus the current market price.

The current financial health read for iTonic Holdings Ltd (NASDAQ-ITOC) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for iTonic Holdings Ltd (NASDAQ-ITOC).

The current market capitalization listed for iTonic Holdings Ltd is 37.409 M.

The current enterprise value listed for iTonic Holdings Ltd is 36.676 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for iTonic Holdings Ltd is NASDAQ-ITOC, and the stock is listed on NASDAQ.

iTonic Holdings Ltd (NASDAQ-ITOC) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for iTonic Holdings Ltd is 0.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for iTonic Holdings Ltd is 91.7%. Free float helps investors understand how much of the share base is available for public trading.

Similar Health Care Technology Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

VEEV NYSE Veeva Systems Inc Class A Fair Value Fair Market Cap 42.13 B
WAY NASDAQ Waystar Holding Corp Fair Value Undervalued Market Cap 4.92 B
DOCS NYSE Doximity Inc Fair Value Undervalued Market Cap 4.654 B
HTFL NASDAQ Heartflow Inc Fair Value Overvalued Market Cap 4.413 B
SDGR NASDAQ Schrodinger Inc Fair Value Overvalued Market Cap 2.171 B
CERT NASDAQ Certara Inc Fair Value Undervalued Market Cap 1.284 B
GDRX NASDAQ Goodrx Holdings Inc Fair Value Undervalued Market Cap 1.153 B
TDOC NYSE Teladoc Inc Fair Value Undervalued Market Cap 1.145 B
HSTM NASDAQ HealthStream Inc Fair Value Fair Market Cap 893.1 M
SOPH NASDAQ Sophia Genetics SA Fair Value Overvalued Market Cap 698.9 M
PHR NYSE Phreesia Inc Fair Value Undervalued Market Cap 623.2 M
CTEV NYSE Claritev Corp Fair Value Fair Market Cap 522.2 M
EVH NYSE Evolent Health Inc Fair Value Undervalued Market Cap 417.2 M
SLP NASDAQ Simulations Plus Inc Fair Value Undervalued Market Cap 372.9 M
AMWL NYSE American Well Corp Fair Value Fair Market Cap 233.9 M
LFMD NASDAQ LifeMD Inc Fair Value Undervalued Market Cap 155.4 M
DH NASDAQ Definitive Healthcare Corp Fair Value Bargain Market Cap 138.8 M
OPRX NASDAQ OPTIMIZERx Corp Fair Value Bargain Market Cap 136.7 M
HCAT NASDAQ Health Catalyst Inc Fair Value Fair Market Cap 134 M
CCLD NASDAQ CareCloud Inc Fair Value Fair Market Cap 91.787 M